Misplaced Pages

Richard Barker (businessman)

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by Prof Richard Barker (talk | contribs) at 20:27, 25 August 2024 (Updated Richard Barker's career details, including his current and past board memberships, and added his role as a visiting professor at King's College London. Adjusted references and formatting for accuracy.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 20:27, 25 August 2024 by Prof Richard Barker (talk | contribs) (Updated Richard Barker's career details, including his current and past board memberships, and added his role as a visiting professor at King's College London. Adjusted references and formatting for accuracy.)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Healthcare leader and precision medicine expert

Prof. Richard Barker OBE FFPM is a healthcare leader known for his forward-thinking approach and innovative contributions to the field. He co-founded and chairs Metadvice, a company developing AI-driven healthcare platforms. He also established New Medicine Partners and is the Founding Director of the University of Oxford’s Centre for the Advancement of Sustainable Medical Innovation (CASMI) in collaboration with University College London. Barker is the chair of the advisory board at NWPharmaTech and a co-founder and board member of 2BWell, a mental health initiative supporting Ukrainians. Additionally, he is a visiting professor in Precision Population Health at King’s College London.


Prof. Richard Barker
Occupation(s)Healthcare Leader and Precision Medicine and Longevity Expert
Known forFounder of New Medicine Partners, Co-founder of Metadvice, and Founding Director of the University of Oxford’s Centre for Sustainable Medical Innovation. Chair of the Advisory Board at NWPharmaTech and a leader in advancing precision medicine, healthcare innovation, and healthy longevity initiatives.

Early life

Barker was born in South London and attended Alleyn's School in Dulwich, London.


Education

Barker studied chemistry at Exeter College, Oxford, earning a bachelor's degree. He pursued research on the biological applications of magnetic resonance techniques for his PhD in Philosophy at Oxford University, followed by post-doctoral studies in Munich, Germany, and Leeds, England.


Career

Barker's career has spanned Europe and the US, including work with McKinsey & Company from 1980 to 1993, where he led the European healthcare practice. He contributed to the founding of 'London First', a public/private initiative to enhance London's global status. At IBM, he managed the global healthcare business from 1993 to 1996, launching Health Village, an early Internet healthcare application. He later worked at Chiron Corporation, heading the diagnostics business, and served as chairman and CEO of Molecular Staging, focusing on genome amplification technology.

Returning to the UK, Barker led the Association of the British Pharmaceutical Industry (ABPI) from 2004 to 2011, supporting initiatives in stratified medicine and translational partnerships between academia and industry. He co-founded the Centre for the Advancement of Sustainable Medical Innovation (CASMI) in 2012 and held an associate professorship at Oxford University until 2017. Barker previously chaired the South London Academic Health Science Network and the charity International Health Partners.

Currently, Barker is the chairman and co-founder of Metadvice, which develops AI-driven healthcare platforms. He is also the founder and chairman of New Medicine Partners, where he advises on precision medicine and health. As a recognized futurist in healthcare, Barker serves as the chair of the advisory board at NWPharmaTech and is a co-founder and board member of 2BWell, a mental health chatbot initiative supporting Ukrainians. Additionally, he is a visiting professor in Precision Population Health at King's College London, reflecting his ongoing commitment to advancing healthcare innovation and public health.


Board memberships

Richard Barker is the Founder and Chairman of New Medicine Partners, Co-founder and Chairman of Metadvice, Chair of the Advisory Board at NWPharmaTech, and Co-founder and Board Member of 2BWell. He has previously served as Chairman and CEO of Molecular Staging, chaired the South London Academic Health Science Network, contributed to International Health Partners, and served on the board of Celgene Corporation.


Awards

Richard Barker was appointed Officer of the Order of the British Empire (OBE) in 2011 for his contributions to the pharmaceutical industry. In 2021, he was awarded an Honorary Fellowship by the Faculty of Pharmaceutical Medicine, recognizing his significant impact on the field.


Published works

Books
  • Barker, Richard (2010). 2030: The Future of Medicine, Oxford University Press, 118 pages. ISBN 978-0199600663
  • Barker, Richard (2016). Bioscience — Lost in Translation?, Oxford University Press, 226 pages. ISBN 978-0198737780


Selected Articles
  • Barker, Richard W.; and Sarah Garner. "Adaptive Drug Development and Licensing", Regulatory Rapporteur, Vol. 9, No. 10, p. 13, October 2012.
  • Barker, Richard. "A Flexible Blueprint for the Future of Drug Development", The Lancet, Vol. 375, Issue 9712, pp. 357–359, 30 January 2010.
  • See CASMI website.


References

  1. "Metadvice". Retrieved 2024-08-25.
  2. "New Medicine Partners". Retrieved 2024-08-25.
  3. "Dr Richard Barker OBE". CASMI. Archived from the original on 2013-04-23. Retrieved 2013-02-11.
  4. "NWPharmaTech". Retrieved 2024-08-25.
  5. "2BWell". Retrieved 2024-08-25.
  6. "Home - Alleyn's School". www.alleyns.org.uk. Retrieved 2024-08-25.
  7. "Homepage". Exeter College. Retrieved 2024-08-25.
  8. "ABPI Honorary Fellows". Retrieved 2024-08-25.
  9. "International Health Partners". Retrieved 2024-08-25.
  10. "Metadvice". Retrieved 2024-08-25.
  11. "New Medicine Partners". Retrieved 2024-08-25.
  12. "NWPharmaTech". Retrieved 2024-08-25.
  13. "2BWell". Retrieved 2024-08-25.
  14. "New Medicine Partners". Retrieved 2024-08-25.
  15. "Metadvice". Retrieved 2024-08-25.
  16. "NWPharmaTech". Retrieved 2024-08-25.
  17. "2BWell". Retrieved 2024-08-25.
  18. "International Health Partners". Retrieved 2024-08-25.
Categories: